Back to results
US 8,409,590 B2Granted
Anthrax antigens and methods of use
AssigneeLigocyte Pharmaceuticals, Inc.
InventorSusan Wimer-Mackin
Life of this patent
Estimating the term…
Abstract
Anthrax antigens are provided that find use as immunogens and vaccines.
Claims16
A dry powder immunogenic composition formulated for mucosal surface administration comprising unconjugated protective antigen (PA), chitosan, and MPL.
Dependencies are inferred from the claim text.